Prediction of outcome in multiple sclerosis based on multivariate models

An incidence cohort of 308 multiple sclerosis patients was followed up repeatedly during at least 25 years of disease. In the patients with acute onset, multivariate survival analyses were performed and predictive models created. The endpoints DSS 6 and start of progressive disease were used. A number of variables were tested. The most important of these for prediction and therefore included in these models were: age at onset, sex, degree of remission after relapse, mono- or polyregional symptoms, type of affected nerve fibres, number of affected neurological systems. The relapse rate did not correlate with prognosis. In the predictive models, coefficients and risk ratios are provided that can be used for calculating the risk of progression and DSS 6 or to predict the median time for these endpoints in individual patients. It was also found that the risk of progression is not constant, but has a maximum a certain time after disease onset. For a patient with early onset, the risk is low in the beginning, but reaches a maximum level, which is several times higher, after about 15 years. The patient with a late onset has a much higher risk of endpoint immediately after onset, but reaches the maximum in a few years, and after that the risk decreases

[1]  Paty Dw,et al.  Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article]. , 2001, Neurology.

[2]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[3]  D. Cox,et al.  Analysis of Survival Data. , 1986 .

[4]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. , 1999, Brain : a journal of neurology.

[5]  N. Koch-Henriksen An epidemiological study of multiple sclerosis. Familial aggregation social determinants, and exogenic factors. , 1989, Acta neurologica Scandinavica. Supplementum.

[6]  K. Lauer,et al.  Early prognostic factors for disability in multiple sclerosis, a European multicenter study , 1992, Acta neurologica Scandinavica.

[7]  O. Andersen Restricted dissemination of clinically defined attacks in an MS incidence material. , 1980, Acta neurologica Scandinavica. Supplementum.

[8]  N. E. Breslow Statistical Methods in Cancer Research , 1986 .

[9]  O. Andersen,et al.  Clinical studies on multiple sclerosis , 1981, Acta neurologica Scandinavica.

[10]  D. Nagaraja,et al.  Prognosis in solitary intraventricular haemorrhage , 1989 .

[11]  G. Ebers The natural history of multiple sclerosis , 2000, Neurological Sciences.

[12]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. , 1989, Brain : a journal of neurology.

[13]  M. Kjær,et al.  Visual evoked potentials in normal subjects and patients with multiple sclerosis , 1980 .

[14]  N E Day,et al.  Statistical methods in cancer research. IARC Workshop 25-27 May 1983. , 1987, IARC scientific publications.

[15]  P. Duquette,et al.  Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. , 1993 .

[16]  O. Andersen,et al.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. , 1993, Brain : a journal of neurology.

[17]  A. Svenningsson,et al.  Incidence of MS during two fifteen‐year periods in the Gothenburg region of Sweden , 1990, Acta neurologica Scandinavica.

[18]  G. Aimard,et al.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. , 1980, Brain : a journal of neurology.

[19]  O. Combarros,et al.  Motor neuron disease in Cantabria , 1988, Acta neurologica Scandinavica.

[20]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[21]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. , 1991, Brain : a journal of neurology.